Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survival.

Morin O, Chen WC, Nassiri F, Susko M, Magill ST, Vasudevan HN, Wu A, Vallières M, Gennatas ED, Valdes G, Pekmezci M, Alcaide-Leon P, Choudhury A, Interian Y, Mortezavi S, Turgutlu K, Bush NAO, Solberg TD, Braunstein SE, Sneed PK, Perry A, Zadeh G, McDermott MW, Villanueva-Meyer JE, Raleigh DR.

Neurooncol Adv. 2019 May-Dec;1(1):vdz011. doi: 10.1093/noajnl/vdz011. Epub 2019 Aug 28.

2.

Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival.

Chapman CH, Hara JH, Molinaro AM, Clarke JL, Oberheim Bush NA, Taylor JW, Butowski NA, Chang SM, Fogh SE, Sneed PK, Nakamura JL, Raleigh DR, Braunstein SE.

Neurooncol Pract. 2019 Sep;6(5):364-374. doi: 10.1093/nop/npz017. Epub 2019 Apr 12.

PMID:
31555451
3.

Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas.

Sloan EA, Cooney T, Oberheim Bush NA, Buerki R, Taylor J, Clarke JL, Torkildson J, Kline C, Reddy A, Mueller S, Banerjee A, Butowski N, Chang S, Mummaneni PV, Chou D, Tan L, Theodosopoulos P, McDermott M, Berger M, Raffel C, Gupta N, Sun PP, Li Y, Shah V, Cha S, Braunstein S, Raleigh DR, Samuel D, Scharnhorst D, Fata C, Guo H, Moes G, Kim JYH, Koschmann C, Van Ziffle J, Onodera C, Devine P, Grenert JP, Lee JC, Pekmezci M, Phillips JJ, Tihan T, Bollen AW, Perry A, Solomon DA.

Acta Neuropathol. 2019 Nov;138(5):877-881. doi: 10.1007/s00401-019-02072-2. Epub 2019 Sep 12. No abstract available.

PMID:
31515627
4.

Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy.

Wang S, Blaha C, Santos R, Huynh T, Hayes TR, Beckford-Vera DR, Blecha JE, Hong AS, Fogarty M, Hope TA, Raleigh DR, Wilson DM, Evans MJ, VanBrocklin HF, Ozawa T, Flavell RR.

Mol Pharm. 2019 Sep 3;16(9):3831-3841. doi: 10.1021/acs.molpharmaceut.9b00464. Epub 2019 Aug 16.

PMID:
31381351
5.

Preoperative Dural Contact and Recurrence Risk After Surgical Cavity Stereotactic Radiosurgery for Brain Metastases: New Evidence in Support of Consensus Guidelines.

Susko M, Yu Y, Ma L, Nakamura J, Fogh S, Raleigh DR, Golden E, Theodosopoulos PV, McDermott MW, Sneed PK, Braunstein SE.

Adv Radiat Oncol. 2019 Mar 14;4(3):458-465. doi: 10.1016/j.adro.2019.03.002. eCollection 2019 Jul-Sep.

6.

Clinical, radiological, and histopathological predictors for long-term prognosis after surgery for atypical meningiomas.

Streckert EMS, Hess K, Sporns PB, Adeli A, Brokinkel C, Kriz J, Holling M, Eich HT, Paulus W, Spille DC, van Eck ATCJ, Raleigh DR, McDermott MW, Stummer W, Brokinkel B.

Acta Neurochir (Wien). 2019 Aug;161(8):1647-1656. doi: 10.1007/s00701-019-03956-8. Epub 2019 May 31.

PMID:
31147831
7.

Meningioma metastases: incidence and proposed screening paradigm.

Dalle Ore CL, Magill ST, Yen AJ, Shahin MN, Lee DS, Lucas CG, Chen WC, Viner JA, Aghi MK, Theodosopoulos PV, Raleigh DR, Villanueva-Meyer JE, McDermott MW.

J Neurosurg. 2019 Apr 5:1-9. doi: 10.3171/2019.1.JNS181771. [Epub ahead of print]

PMID:
30952122
8.

Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma.

Voce DJ, Bernal GM, Wu L, Crawley CD, Zhang W, Mansour NM, Cahill KE, Szymura SJ, Uppal A, Raleigh DR, Spretz R, Nunez L, Larsen G, Khodarev NN, Weichselbaum RR, Yamini B.

Cancer Res. 2019 May 15;79(10):2536-2548. doi: 10.1158/0008-5472.CAN-18-2170. Epub 2019 Apr 2.

PMID:
30940658
9.

Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma.

Lee JC, Mazor T, Lao R, Wan E, Diallo AB, Hill NS, Thangaraj N, Wendelsdorf K, Samuel D, Kline CN, Banerjee A, Auguste K, Raffel C, Gupta N, Berger M, Raleigh DR, Shai A, Phillips JJ, Bollen AW, Tihan T, Perry A, Costello J, Solomon DA.

Acta Neuropathol. 2019 May;137(5):851-854. doi: 10.1007/s00401-019-01990-5. Epub 2019 Mar 14. No abstract available.

10.

Preoperative MR Imaging to Differentiate Chordoid Meningiomas from Other Meningioma Histologic Subtypes.

Baal JD, Chen WC, Solomon DA, Pai JS, Lucas CH, Hara JH, Oberheim Bush NA, McDermott MW, Raleigh DR, Villanueva-Meyer JE.

AJNR Am J Neuroradiol. 2019 Mar;40(3):433-439. doi: 10.3174/ajnr.A5996. Epub 2019 Feb 28.

11.

Surgical Outcomes, Complications, and Management Strategies for Foramen Magnum Meningiomas.

Magill ST, Shahin MN, Lucas CG, Yen AJ, Lee DS, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW.

J Neurol Surg B Skull Base. 2019 Feb;80(1):1-9. doi: 10.1055/s-0038-1654702. Epub 2018 May 28.

PMID:
30733894
12.

Erratum: "Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers" [Med. Phys. 45 (7), 3449-3459 (2018)].

Deist TM, Dankers FJWM, Valdes G, Wijsman R, Hsu IC, Oberije C, Lustberg T, van Soest J, Hoebers F, Jochems A, El Naqa I, Wee L, Morin O, Raleigh DR, Bots W, Kaanders JH, Belderbos J, Kwint M, Solberg T, Monshouwer R, Bussink J, Dekker A, Lambin P.

Med Phys. 2019 Feb;46(2):1080-1087. doi: 10.1002/mp.13329. Epub 2019 Jan 7. No abstract available.

PMID:
30730570
13.

Misactivation of Hedgehog signaling causes inherited and sporadic cancers.

Raleigh DR, Reiter JF.

J Clin Invest. 2019 Feb 1;129(2):465-475. doi: 10.1172/JCI120850. Epub 2019 Feb 1. Review.

14.

Advances in multidisciplinary therapy for meningiomas.

Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, McDermott MW, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn JC, Wen PY, Aldape K, Nassiri F, Zadeh G, Jenkinson MD, Raleigh DR; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i18-i31. doi: 10.1093/neuonc/noy136.

15.

The impact of histopathology and NAB2-STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma.

Fritchie K, Jensch K, Moskalev EA, Caron A, Jenkins S, Link M, Brown PD, Rodriguez FJ, Guajardo A, Brat D, Velázquez Vega JE, Perry A, Wu A, Raleigh DR, Santagata S, Louis DN, Brastianos PK, Kaplan A, Alexander BM, Rossi S, Ferrarese F, Haller F, Giannini C.

Acta Neuropathol. 2019 Feb;137(2):307-319. doi: 10.1007/s00401-018-1952-6. Epub 2018 Dec 24.

16.

Surgical outcomes after reoperation for recurrent non-skull base meningiomas.

Magill ST, Dalle Ore CL, Diaz MA, Jalili DD, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW.

J Neurosurg. 2018 Nov 1:1-9. doi: 10.3171/2018.6.JNS18118. [Epub ahead of print]

PMID:
30544357
17.

Cilia-Associated Oxysterols Activate Smoothened.

Raleigh DR, Sever N, Choksi PK, Sigg MA, Hines KM, Thompson BM, Elnatan D, Jaishankar P, Bisignano P, Garcia-Gonzalo FR, Krup AL, Eberl M, Byrne EFX, Siebold C, Wong SY, Renslo AR, Grabe M, McDonald JG, Xu L, Beachy PA, Reiter JF.

Mol Cell. 2018 Oct 18;72(2):316-327.e5. doi: 10.1016/j.molcel.2018.08.034.

18.

Preoperative and postoperative prediction of long-term meningioma outcomes.

Gennatas ED, Wu A, Braunstein SE, Morin O, Chen WC, Magill ST, Gopinath C, Villaneueva-Meyer JE, Perry A, McDermott MW, Solberg TD, Valdes G, Raleigh DR.

PLoS One. 2018 Sep 20;13(9):e0204161. doi: 10.1371/journal.pone.0204161. eCollection 2018.

19.

Clinical Applications of Quantitative 3-Dimensional MRI Analysis for Pediatric Embryonal Brain Tumors.

Hara JH, Wu A, Villanueva-Meyer JE, Valdes G, Daggubati V, Mueller S, Solberg TD, Braunstein SE, Morin O, Raleigh DR.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):744-756. doi: 10.1016/j.ijrobp.2018.05.077. Epub 2018 Jun 8.

PMID:
30108003
20.

Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers.

Deist TM, Dankers FJWM, Valdes G, Wijsman R, Hsu IC, Oberije C, Lustberg T, van Soest J, Hoebers F, Jochems A, El Naqa I, Wee L, Morin O, Raleigh DR, Bots W, Kaanders JH, Belderbos J, Kwint M, Solberg T, Monshouwer R, Bussink J, Dekker A, Lambin P.

Med Phys. 2018 Jul;45(7):3449-3459. doi: 10.1002/mp.12967. Epub 2018 Jun 13. Erratum in: Med Phys. 2019 Feb;46(2):1080-1087.

21.

Surgical outcomes after reoperation for recurrent skull base meningiomas.

Magill ST, Lee DS, Yen AJ, Lucas CG, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW.

J Neurosurg. 2018 May 4;130(3):876-883. doi: 10.3171/2017.11.JNS172278.

PMID:
29726777
22.

Case-based review: pediatric medulloblastoma.

Kline CN, Packer RJ, Hwang EI, Raleigh DR, Braunstein S, Raffel C, Bandopadhayay P, Solomon DA, Aboian M, Cha S, Mueller S.

Neurooncol Pract. 2017 Sep;4(3):138-150. doi: 10.1093/nop/npx011. Epub 2017 Aug 11. Review.

23.

How the Ciliary Membrane Is Organized Inside-Out to Communicate Outside-In.

Garcia G 3rd, Raleigh DR, Reiter JF.

Curr Biol. 2018 Apr 23;28(8):R421-R434. doi: 10.1016/j.cub.2018.03.010. Review.

24.

Petrous Face Meningiomas: Classification, Clinical Syndromes, and Surgical Outcomes.

Magill ST, Rick JW, Chen WC, Haase DA, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW.

World Neurosurg. 2018 Jun;114:e1266-e1274. doi: 10.1016/j.wneu.2018.03.194. Epub 2018 Apr 4.

25.

Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.

Chen WC, Magill ST, Wu A, Vasudevan HN, Morin O, Aghi MK, Theodosopoulos PV, Perry A, McDermott MW, Sneed PK, Braunstein SE, Raleigh DR.

J Neurosurg. 2018 Apr 6;130(2):443-450. doi: 10.3171/2017.9.JNS171609.

PMID:
29624151
26.

Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation.

Vasudevan HN, Braunstein SE, Phillips JJ, Pekmezci M, Tomlin BA, Wu A, Reis GF, Magill ST, Zhang J, Feng FY, Nicholaides T, Chang SM, Sneed PK, McDermott MW, Berger MS, Perry A, Raleigh DR.

Cell Rep. 2018 Mar 27;22(13):3672-3683. doi: 10.1016/j.celrep.2018.03.013.

27.

Salvage therapy outcomes for atypical meningioma.

Chen WC, Hara J, Magill ST, Wu A, Aghi MK, Theodosopoulos PV, Perry A, McDermott MW, Sneed PK, Raleigh DR, Braunstein SE.

J Neurooncol. 2018 Jun;138(2):425-433. doi: 10.1007/s11060-018-2813-9. Epub 2018 Feb 26.

PMID:
29480505
28.

Presenting Symptoms and Prognostic Factors for Symptomatic Outcomes Following Resection of Meningioma.

Wu A, Garcia MA, Magill ST, Chen W, Vasudevan HN, Perry A, Theodosopoulos PV, McDermott MW, Braunstein SE, Raleigh DR.

World Neurosurg. 2018 Mar;111:e149-e159. doi: 10.1016/j.wneu.2017.12.012. Epub 2017 Dec 14.

PMID:
29248774
29.

Hedgehog signaling drives medulloblastoma growth via CDK6.

Raleigh DR, Choksi PK, Krup AL, Mayer W, Santos N, Reiter JF.

J Clin Invest. 2018 Jan 2;128(1):120-124. doi: 10.1172/JCI92710. Epub 2017 Nov 20.

30.

Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy.

Vasudevan HN, Raleigh DR, Johnson J, Garsa AA, Theodosopoulos PV, Aghi MK, Ames C, McDermott MW, Barani IJ, Braunstein SE.

Front Surg. 2017 Jun 23;4:35. doi: 10.3389/fsurg.2017.00035. eCollection 2017.

31.

Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.

Kline CN, Joseph NM, Grenert JP, van Ziffle J, Talevich E, Onodera C, Aboian M, Cha S, Raleigh DR, Braunstein S, Torkildson J, Samuel D, Bloomer M, Campomanes AGA, Banerjee A, Butowski N, Raffel C, Tihan T, Bollen AW, Phillips JJ, Korn WM, Yeh I, Bastian BC, Gupta N, Mueller S, Perry A, Nicolaides T, Solomon DA.

Neuro Oncol. 2017 May 1;19(5):699-709. doi: 10.1093/neuonc/now254. Erratum in: Neuro Oncol. 2017 Apr 1;19(4):601.

32.

Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients.

Raleigh DR, Tomlin B, Buono BD, Roddy E, Sear K, Byer L, Felton E, Banerjee A, Torkildson J, Samuel D, Horn B, Braunstein SE, Haas-Kogan DA, Mueller S.

J Neurooncol. 2017 Jan;131(2):359-368. doi: 10.1007/s11060-016-2307-6. Epub 2016 Oct 24.

PMID:
27778212
33.

Educational Impact of a Structured Radiation Oncology Clerkship Curriculum: An Interinstitutional Comparison.

Oskvarek JJ, Brower JV, Mohindra P, Raleigh DR, Chmura SJ, Golden DW.

J Am Coll Radiol. 2017 Jan;14(1):96-102. doi: 10.1016/j.jacr.2016.07.017. Epub 2016 Sep 18.

34.

Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis.

Raleigh DR, Seymour ZA, Tomlin B, Theodosopoulos PV, Berger MS, Aghi MK, Geneser SE, Krishnamurthy D, Fogh SE, Sneed PK, McDermott MW.

J Neurosurg. 2017 Jun;126(6):1749-1755. doi: 10.3171/2016.4.JNS152530. Epub 2016 Jul 1.

PMID:
27367240
35.

Discovery of additional brain metastases on the day of stereotactic radiosurgery: risk factors and outcomes.

Garcia MA, Lazar A, Duriseti S, Raleigh DR, Hess CP, Fogh SE, Barani IJ, Nakamura JL, Larson DA, Theodosopoulos P, McDermott M, Sneed PK, Braunstein S.

J Neurosurg. 2017 Jun;126(6):1756-1763. doi: 10.3171/2016.4.JNS152319. Epub 2016 Jul 1.

PMID:
27367235
36.

Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome.

Raleigh DR, Solomon DA, Lloyd SA, Lazar A, Garcia MA, Sneed PK, Clarke JL, McDermott MW, Berger MS, Tihan T, Haas-Kogan DA.

Neuro Oncol. 2017 Jan;19(1):78-88. doi: 10.1093/neuonc/now105. Epub 2016 Jun 9. Erratum in: Neuro Oncol. 2017 Nov 29;19(12):1702.

37.

Surgical Resection and Interstitial Iodine-125 Brachytherapy for High-Grade Meningiomas: A 25-Year Series.

Magill ST, Lau D, Raleigh DR, Sneed PK, Fogh SE, McDermott MW.

Neurosurgery. 2017 Mar 1;80(3):409-416. doi: 10.1227/NEU.0000000000001262.

PMID:
27258768
38.

Parameters influencing local control of meningiomas treated with radiosurgery.

Kaprealian T, Raleigh DR, Sneed PK, Nabavizadeh N, Nakamura JL, McDermott MW.

J Neurooncol. 2016 Jun;128(2):357-64. doi: 10.1007/s11060-016-2121-1. Epub 2016 Apr 30.

PMID:
27131883
39.

Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature.

Vaubel RA, Chen SG, Raleigh DR, Link MJ, Chicoine MR, Barani I, Jenkins SM, Aleff PA, Rodriguez FJ, Burger PC, Dahiya S, Perry A, Giannini C.

J Neuropathol Exp Neurol. 2016 Jan;75(1):44-52. doi: 10.1093/jnen/nlv006. Epub 2015 Dec 7. Review.

40.

Patient- and treatment-specific predictors of genitourinary function after high-dose-rate monotherapy for favorable prostate cancer.

Raleigh DR, Chang AJ, Tomlin B, Cunha JA, Braunstein SE, Shinohara K, Gottschalk AR, Roach M 3rd, Hsu IC.

Brachytherapy. 2015 Nov-Dec;14(6):795-800. doi: 10.1016/j.brachy.2015.06.004. Epub 2015 Jul 18.

PMID:
26198421
41.

Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen.

Menke JR, Raleigh DR, Gown AM, Thomas S, Perry A, Tihan T.

Acta Neuropathol. 2015 Sep;130(3):441-3. doi: 10.1007/s00401-015-1459-3. Epub 2015 Jul 21. No abstract available.

42.

Induction Hedgehog pathway inhibition followed by combined-modality radiotherapy for basal cell carcinoma.

Raleigh DR, Algazi A, Arron ST, Neuhaus IM, Yom SS.

Br J Dermatol. 2015 Aug;173(2):544-6. doi: 10.1111/bjd.13748. Epub 2015 Jun 11.

PMID:
25702621
43.

S-phase-dependent p50/NF-кB1 phosphorylation in response to ATR and replication stress acts to maintain genomic stability.

Crawley CD, Kang S, Bernal GM, Wahlstrom JS, Voce DJ, Cahill KE, Garofalo A, Raleigh DR, Weichselbaum RR, Yamini B.

Cell Cycle. 2015;14(4):566-76. doi: 10.4161/15384101.2014.991166.

44.

Toward an improved understanding of the ionizing radiation induced DNA damage/response networks in human malignancies.

Haas-Kogan DA, Raleigh DR, Dicker AP.

Front Oncol. 2014 Dec 4;4:335. doi: 10.3389/fonc.2014.00335. eCollection 2014. No abstract available.

45.

Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapy.

Raleigh DR, Hsu IC, Braunstein S, Chang AJ, Simko JP, Roach M 3rd.

Brachytherapy. 2015 Mar-Apr;14(2):185-8. doi: 10.1016/j.brachy.2014.11.008. Epub 2014 Dec 19.

PMID:
25533416
46.

The management of central neurocytoma: radiotherapy.

Barani IJ, Raleigh DR, Larson D.

Neurosurg Clin N Am. 2015 Jan;26(1):45-56. doi: 10.1016/j.nec.2014.09.014. Review.

PMID:
25432183
47.

Non-Muscle Myosin IIa Heavy Chain Links Squamous-Cell Carcinoma of the Head and Neck to the DNA Damage Response.

Raleigh DR, Haas-Kogan DA.

Front Oncol. 2014 Aug 25;4:228. doi: 10.3389/fonc.2014.00228. eCollection 2014. No abstract available.

48.

A national radiation oncology medical student clerkship survey: didactic curricular components increase confidence in clinical competency.

Jagadeesan VS, Raleigh DR, Koshy M, Howard AR, Chmura SJ, Golden DW.

Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):51-6. doi: 10.1016/j.ijrobp.2013.11.206.

49.

Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux.

Buschmann MM, Shen L, Rajapakse H, Raleigh DR, Wang Y, Wang Y, Lingaraju A, Zha J, Abbott E, McAuley EM, Breskin LA, Wu L, Anderson K, Turner JR, Weber CR.

Mol Biol Cell. 2013 Oct;24(19):3056-68. doi: 10.1091/mbc.E12-09-0688. Epub 2013 Aug 7.

50.

Molecular targets and mechanisms of radiosensitization using DNA damage response pathways.

Raleigh DR, Haas-Kogan DA.

Future Oncol. 2013 Feb;9(2):219-33. doi: 10.2217/fon.12.185. Review.

Supplemental Content

Loading ...
Support Center